Pacira BioSciences Inc (PCRX)
19.43
+0.46
(+2.42%)
USD |
NASDAQ |
Dec 23, 11:00
Pacira BioSciences Shareholders Equity (Quarterly): 749.58M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cyclo Therapeutics Inc | -13.47M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
| Theriva Biologics Inc | 24.64M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.522B |
| Total Liabilities (Quarterly) | 772.11M |
| Debt to Equity Ratio | 0.7836 |
| Current Ratio | 2.252 |
| Net Debt Paydown Yield | -1.03% |